Resolution of subretinal haemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization
Open Access
- 22 June 2006
- journal article
- case report
- Published by Wiley in Acta Ophthalmologica Scandinavica
- Vol. 84 (5), 707-708
- https://doi.org/10.1111/j.1600-0420.2006.00736.x
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Neovascular Age-Related Macular DegenerationOphthalmic Surgery, Lasers and Imaging Retina, 2005
- Ocular Conditions Associated with Peripapillary Subretinal Neovascularization, Their Relative Frequencies, and Associated OutcomesOphthalmology, 2005
- Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical StudyOphthalmology, 2005
- Bevacizumab suppresses choroidal neovascularisation caused by pathological myopiaBritish Journal of Ophthalmology, 2005
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004